Drugs / 18F-FCH
18F-FCH
English name 18F-Fluorocholine
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01395030 | Aug 2011 → May 2017 | adult hepatocellular carcinoma | Queen's Medical Center | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT07444723 | Apr 2026 → Feb 2035 expected | hyperparathyroidism 2 with jaw tumors, multiple endocrine neoplasia, parathyroid gland carcinoma | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Recruiting | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT03891914 | Nov 2019 → Jan 2023 | plasma cell myeloma | University Hospital, Bordeaux | Completed | No outcome recorded |
| Phase 3 | NCT03623425 | Feb 2019 → May 2020 | prostate cancer | Central Hospital, Nancy, France | Unknown | No outcome recorded |
| Phase 3 | NCT02840552 | Sep 2016 → Feb 2018 | prostate cancer | Sir Mortimer B. Davis - Jewish General Hospital | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01956409 | Sep 2012 → Dec 2016 | female breast carcinoma | National Taiwan University Hospital | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 18F-FCH | “18F-Fluoromethylcholine (18F-FCH) PET/CT” NCT02840552 ↗ |
| Known as | 18F-choline | “18F-choline has shown increased sensitivity when compared with 18-FDG, with about 75% more lesions detected in patients with relapsed or progressive multiple myeloma (MM).” PMID 32909953 ↗ Sep 2020 |
| Known as | 18F-Fluoromethylcholine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02840552 ↗ |
| Known as | fluorocholine | “with the injection of a radiopharmaceutical drug, the 18F-FCH(or fluorocholine) for the detection of bone lesions” NCT03891914 ↗1“18F-fluoromethylcholine (aka fluorocholine or FCH)” NCT02840552 ↗ |
| Modality | Diagnostic / imaging agent | “Diagnostic procedures, such as fluorine-18 fluoromethylcholine PET/CT, may help find and diagnose liver cancer.” NCT01395030 ↗ |